Page title

Harm Reduction Grant Program

Main page content

Short Title
Harm Reduction
Modified Announcement

The priority population language and Evaluation Criteria C.1 table has been updated.

Notice of Funding Opportunity (NOFO)
NOFO Number
SP-22-001
Posted on Grants.gov
Application Due Date
Catalog of Federal Domestic Assistance (CFDA) Number
93.243
Intergovernmental Review (E.O. 12372)
Applicants must comply with E.O. 12372 if their state(s) participates. Review process recommendations from the State Single Point of Contact (SPOC) are due no later than 60 days after application deadline.
Public Health System Impact Statement (PHSIS) / Single State Agency Coordination
Applicants must send the PHSIS to appropriate State and local health agencies by application deadline. Comments from Single State Agency are due no later than 60 days after application deadline.
Description

The purpose of the program is to support community-based overdose prevention programs, syringe services programs, and other harm reduction services. Funding will be used to enhance overdose and other types of prevention activities to help control the spread of infectious diseases and the consequences of such diseases for individuals with, or at risk of developing substance use disorders (SUD), support distribution of FDA-approved overdose reversal medication to individuals at risk of overdose, build connections for individuals at risk for, or with, a SUD to overdose education, counseling, and health education, refer individuals to treatment for infectious diseases such as HIV, sexually transmitted infections (STIs), and viral hepatitis, and encourage such individuals to take steps to reduce the negative personal and public health impacts of substance use or misuse. This will include supporting capacity development to strengthen harm reduction programs as part of the continuum of care. Recipients will also establish processes, protocols, and mechanisms for referral to appropriate treatment and recovery support services. Grantees will also provide overdose prevention education to their target populations regarding the consumption of substances including but not limited to opioids and their synthetic analogs. Funds may also be used to help address the stigma often associated with substance use and participation in harm reduction activities.

Eligibility

Eligible applicants are States; local, Tribal, and territorial governments; Tribal organizations; non-profit community-based organizations; and primary and behavioral health organizations

Award Information
Funding Mechanism
Grant
Anticipated Total Available Funding
Up to $9,750,000 per year or $29,250,000 over 3 years
Anticipated Number of Awards
25 awards
Anticipated Award Amount
Up to $400,000 per award per year
Length of Project
Up to 3 years
Cost Sharing/Match Required?
No

Proposed budgets cannot exceed $400,000 in total costs (direct and indirect) in any year of the proposed project. Annual continuation awards will depend on the availability of funds, grantee progress in meeting project goals and objectives, timely submission of required data and reports, and compliance with all terms and conditions of award.)

Contact Information
Program Issues

Cara Alexander
Center for Substance Abuse Prevention
Substance Abuse and Mental Health Services Administration
(240) 276-0578
DTPHarmReduction@samhsa.hhs.gov

Grants Management and Budget Issues

Office of Financial Resources, Division of Grants Management
Substance Abuse and Mental Health Services Administration
(240) 276-1400
FOACSAP@samhsa.hhs.gov

Last Updated

Last Updated: 03/02/2022